Polyclonal Antibody to Breast Cancer Susceptibility Protein 2 (BRCA2) is a premium-quality life science research product supplied by Torvigen for laboratory and scientific applications.
BRCA2; BRCC2; FACD; FAD; FAD1; FANCD; FANCD1; Breast Cancer 2, Early Onset; Breast Cancer Type 2 Susceptibility Protein; Fanconi anemia group D1 protein
Name Synonym
Breast Cancer Susceptibility Protein 2
Uniprot
O35923
Field of Research
Tumor immunity; Genetic science
Applications
WB; IHC; ICC; IP.
Organism Species
Rattus norvegicus (Rat)
Concentration
0.5mg/ml
Buffer
PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Host
Rabbit
Host or Source
Rabbit
Source
Polyclonal antibody preparation
Immunogen
RPB364Ra01-Recombinant Breast Cancer Susceptibility Protein 2 (BRCA2)
Recommended Usage
Western blotting: 0.01-2μg/mL; < br/> Immunohistochemistry: 5-20μg/mL; < br/> Immunocytochemistry: 5-20μg/mL; < br/> Optimal working dilutions must be determined by end user.
